As of 2025-08-13, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is (5.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.45 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -169.7%.
The range of the Relative Valuation is (4.09) - (7.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.0x - 10.2x | 7.1x |
| Forward P/E multiples | 4.9x - 9.1x | 7.0x |
| Fair Price | (4.09) - (7.60) | (5.89) |
| Upside | -148.4% - -189.9% | -169.7% |
| Date | P/E |
| 2025-08-08 | -9.69 |
| 2025-08-07 | -9.74 |
| 2025-08-06 | -10.24 |
| 2025-08-05 | -10.59 |
| 2025-08-04 | -10.48 |
| 2025-08-01 | -10.34 |
| 2025-07-31 | -9.70 |
| 2025-07-30 | -9.77 |
| 2025-07-29 | -9.97 |
| 2025-07-28 | -9.80 |
| 2025-07-25 | -10.06 |
| 2025-07-24 | -10.05 |
| 2025-07-23 | -10.25 |
| 2025-07-22 | -9.50 |
| 2025-07-21 | -9.43 |
| 2025-07-18 | -9.99 |
| 2025-07-17 | -9.59 |
| 2025-07-16 | -9.37 |
| 2025-07-15 | -9.23 |
| 2025-07-14 | -9.39 |
| 2025-07-11 | -9.22 |
| 2025-07-10 | -9.52 |
| 2025-07-09 | -9.22 |
| 2025-07-08 | -8.32 |
| 2025-07-07 | -8.46 |
| 2025-07-03 | -8.32 |
| 2025-07-02 | -8.08 |
| 2025-07-01 | -7.80 |
| 2025-06-30 | -7.79 |
| 2025-06-27 | -7.99 |
| 2025-06-26 | -8.42 |
| 2025-06-25 | -8.20 |
| 2025-06-24 | -8.18 |
| 2025-06-23 | -8.34 |
| 2025-06-20 | -7.87 |
| 2025-06-18 | -8.26 |
| 2025-06-17 | -7.89 |
| 2025-06-16 | -8.20 |
| 2025-06-13 | -8.32 |
| 2025-06-12 | -8.62 |
| 2025-06-11 | -8.61 |
| 2025-06-10 | -8.66 |
| 2025-06-09 | -8.44 |
| 2025-06-06 | -8.65 |
| 2025-06-05 | -8.08 |
| 2025-06-04 | -8.00 |
| 2025-06-03 | -7.79 |
| 2025-06-02 | -7.49 |
| 2025-05-30 | -7.20 |
| 2025-05-29 | -7.47 |